Stock 4978 REPROCELL INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar ReproCELL Incorporated

Equities

4978

JP3974770004

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-25 am EDT 		5-day change 1st Jan Change
136 JPY -2.16% Intraday chart for ReproCELL Incorporated 0.00% -22.29%
2023 ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd. CI
2023 ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding CI

Chart calendar ReproCELL Incorporated

1e35522c59aaa9f051c05e5.dguJKCoG8UQvYp1r4bcXZpJo4qNGmtyzKC3Y7iRzxPY.DzKwEBoxyAh6FfoeruhONqMnuMsqoqrlXUGSvkE3r441RrEQXEWWCGw2pQ~9b51127f1bd56507702ac410d4a26812

Upcoming events on ReproCELL Incorporated

2024-05-12 Q4 2023 Earnings Release
2024-08-08 Q1 2024 Earnings Release (Projected)
2024-11-07 Q2 2024 Earnings Release (Projected)
2025-02-06 Q3 2024 Earnings Release (Projected)
2025-05-13 Q4 2024 Earnings Release (Projected)

Past events on ReproCELL Incorporated

2024-02-08 Q3 2023 Earnings Release
2023-11-09 Q2 2023 Earnings Release
2023-08-09 Q1 2023 Earnings Release
2023-06-21 Shareholders Meeting
2023-05-11 Q4 2022 Earnings Release
2023-02-09 Q3 2022 Earnings Release
2022-11-08 Interim 2022 Earnings Release
2022-08-09 Q1 2022 Earnings Release
2022-05-12 FY 2021 Earnings Release
2022-02-09 Q3 2022 Earnings Release
2021-11-11 Interim 2021 Earnings Release
2021-08-12 Q1 2021 Earnings Release
2021-05-11 FY 2020 Earnings Release
2021-02-11 Q3 2020 Earnings Release
2020-11-11 Interim 2020 Earnings Release
2020-05-13 FY 2019 Earnings Release
2020-02-12 Q3 2019 Earnings Release
2019-08-08 Q1 2019 Earnings Release
2019-05-13 FY 2018 Earnings Release
2019-02-12 Q3 2018 Earnings Release

Annual results

Fiscal PeriodMarch 2019 2020 2021 2022 2023 2024
Net sales
Million JPY		Released
Forecast
Spread 		1 088
1 200
-9.33%		1 199
1 200
-0.08%		1 286
1 290
-0.31%		2 234
2 060
8.45%		2 953
2 810
5.09%
2 630

EBITDA
Million JPY		Released
Forecast
Spread 		-729
-760
4.12%		-843
-870
3.14%		-987
-1 050
6.04%		-587
-610
3.71%		-176
-160
-9.76%
-400

EBIT
Million JPY		Released
Forecast
Spread 		-781
-860
9.19%		-908
-910
0.22%		-1 048
-1 100
4.73%		-647
-670
3.43%		-356
-220
-61.82%
-460

Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		-627
-810
22.59%		-1 015
-1 010
-0.5%		-811
-950
14.63%		-573
-400
-43.25%		-303
-70,0
-332.86%
-260

Net income
Million JPY		Released
Forecast
Spread 		-601
-810
25.8%		-1 016
-1 010
-0.59%		-812
-950
14.53%		-575
-400
-43.75%		-305
-70,0
-335.71%
-260

EPS
JPY		Released
Forecast
Spread 		-8,79
-11,4
22.89%		-14,3
-14,1
-0.92%		-11,4
-13,3
14.31%		-7,57
-4,52
-67.48%		-3,62
-0,82
-341.46%
-3,05

Announcement Date14/05/1910/07/2012/05/2113/05/2212/05/23-

Quarterly results

Fiscal PeriodMarch 2020 S1 2021 S1 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales
Million JPY		Released
Forecast
Spread 		564


614


989


499
450
10.89%		746
572
30.42%		666
370
80%		910
613
48.39%		1 576


647
670
-3.43%		730
587
24.42%		556
550
1.09%		591
564
4.86%		1 147


629
720
-12.64%
853

EBIT
Million JPY		Released
Forecast
Spread 		-432


-502


-359


-170
-230
26.09%		-118
-141
16.31%		-86,0
-200
57%		-4,00
-93,3
95.71%		-90,0


-117
-80,0
-46.25%		-149
-12,7
-1069.64%		-124
-140
11.43%		-117
-116
-0.93%		-241


-48,0
-90,0
46.67%
-171

Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		-434


-365


-201


-150





42,0





70,0


-106





73,0





61,0


-12,0





Net income
Million JPY		Released
Forecast
Spread 		-436


-365


-201


-150





42,0





68,0


-107





72,0





60,0


-12,0





EPS
JPY		Released
Forecast
Spread 		-6,13


-5,13


-2,79


-1,95
-9,22
78.85%		-2,83
0,22
-1386.36%		0,51
-1,46
134.93%		0,31
-1,24
125%		0,82


-1,29
-0,94
-37.23%		-3,15
-0,35
-800%		0,85
-0,23
469.57%		-0,14
-2,14
93.46%		0,71


-0,14
-0,94
85.11%
-3,62

Announcement Date13/11/1912/11/2012/11/2110/02/2213/05/2210/08/2209/11/2209/11/2210/02/2312/05/2310/08/2310/11/2310/11/2309/02/24-

Upcoming sector events for ReproCELL Incorporated

2024-04-25 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
2024-04-25 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 HUALAN BIOLOGICAL VACCINE INC.: Q1 2024 Earnings Release
2024-04-25 HUALAN BIOLOGICAL ENGINEERING INC.: Q1 2024 Earnings Release
2024-04-25 BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.: Q1 2024 Earnings Release
2024-04-25 ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD.: Q1 2024 Earnings Release
2024-04-25 BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
2024-04-25 CHENGDU OLYMVAX BIOPHARMACEUTICALS INC.: Q4 2023 Earnings Release
2024-04-25 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.: Q4 2023 Earnings Release
More events

Past sector events for ReproCELL Incorporated

Today 02:00 am BONESUPPORT HOLDING AB: Q1 2024 Earnings Release
Today 02:00 am SWEDISH ORPHAN BIOVITRUM AB: Q1 2024 Earnings Release
Today CHENGDU OLYMVAX BIOPHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD.: Q1 2024 Earnings Release (Projected)
Today JIANGSU AIDEA PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
Today GAN & LEE PHARMACEUTICALS.: Q1 2024 Earnings Release
Today GAN & LEE PHARMACEUTICALS.: Q4 2023 Earnings Release
Today WALVAX BIOTECHNOLOGY CO., LTD.: Q1 2024 Earnings Release
Today BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q1 2024 Earnings Release (Projected)
Today PHARMA MAR, S.A.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4978 Stock
  4. Calendar ReproCELL Incorporated